JP2021527098A5 - - Google Patents
Info
- Publication number
- JP2021527098A5 JP2021527098A5 JP2020569169A JP2020569169A JP2021527098A5 JP 2021527098 A5 JP2021527098 A5 JP 2021527098A5 JP 2020569169 A JP2020569169 A JP 2020569169A JP 2020569169 A JP2020569169 A JP 2020569169A JP 2021527098 A5 JP2021527098 A5 JP 2021527098A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- cells
- cancer
- alkyls
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862684495P | 2018-06-13 | 2018-06-13 | |
| US62/684,495 | 2018-06-13 | ||
| PCT/US2019/036581 WO2019241271A1 (en) | 2018-06-13 | 2019-06-11 | Fused thiophene compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021527098A JP2021527098A (ja) | 2021-10-11 |
| JPWO2019241271A5 JPWO2019241271A5 (https=) | 2022-06-10 |
| JP2021527098A5 true JP2021527098A5 (https=) | 2022-06-10 |
| JP7365059B2 JP7365059B2 (ja) | 2023-10-19 |
Family
ID=67263033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020569169A Active JP7365059B2 (ja) | 2018-06-13 | 2019-06-11 | 縮合チオフェン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11191769B2 (https=) |
| EP (1) | EP3807283A1 (https=) |
| JP (1) | JP7365059B2 (https=) |
| CN (1) | CN112601751B (https=) |
| AU (1) | AU2019284605A1 (https=) |
| CA (1) | CA3101335C (https=) |
| TW (1) | TWI826463B (https=) |
| WO (1) | WO2019241271A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10513515B2 (en) * | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| AU2020387392B2 (en) | 2019-11-19 | 2025-09-11 | Bristol-Myers Squibb Company | Compounds useful as inhibitors of Helios protein |
| WO2021155050A1 (en) * | 2020-01-29 | 2021-08-05 | Biotheryx, Inc. | Kinase modulators, pharmaceutical compositions, and therapeutic applications |
| TW202140441A (zh) | 2020-03-23 | 2021-11-01 | 美商必治妥美雅史谷比公司 | 經取代之側氧基異吲哚啉化合物 |
| WO2022061348A1 (en) | 2020-09-16 | 2022-03-24 | Biotheryx, Inc. | Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| CN116583509A (zh) * | 2020-10-07 | 2023-08-11 | 上海睿跃生物科技有限公司 | 治疗癌症的化合物和方法 |
| WO2022087335A1 (en) | 2020-10-23 | 2022-04-28 | Biotheryx, Inc. | Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| TW202237580A (zh) | 2020-12-14 | 2022-10-01 | 美商拜歐斯瑞克斯公司 | Pde4降解劑、醫藥組合物及治療應用 |
| JP2024504932A (ja) | 2021-01-13 | 2024-02-02 | モンテ ローザ セラピューティクス， インコーポレイテッド | イソインドリノン化合物 |
| BR112023020077A2 (pt) | 2021-04-06 | 2023-11-14 | Bristol Myers Squibb Co | Compostos de oxoisoindolina substituída por piridinila |
| WO2023069731A1 (en) * | 2021-10-22 | 2023-04-27 | Monte Rosa Therapeutics, Inc. | Compounds that mediate protein degradation and methods of use thereof |
| US12419962B2 (en) | 2022-03-16 | 2025-09-23 | Biotheryx, Inc. | Quinazolines, pharmaceutical compositions, and therapeutic applications |
| WO2024015855A1 (en) | 2022-07-13 | 2024-01-18 | Monte Rosa Therapeutics, Inc. | COMBINATION THERAPY COMPRISING GSPT1-DIRECTED MOLECULAR GLUE DEGRADERS AND PI3K/AKT/mTOR PATHWAY INHIBITORS |
| CN120303264A (zh) | 2022-09-09 | 2025-07-11 | 医诺康治疗公司 | CK1α和双重CK1α/GSPT1降解化合物 |
| WO2024222918A1 (zh) * | 2023-04-28 | 2024-10-31 | 中国药科大学 | 一种苯并六元杂环类gspt1蛋白降解剂及其应用 |
| CN119371398A (zh) * | 2023-07-25 | 2025-01-28 | 安道麦阿甘有限公司 | 用于制备噻吩酮的新路线 |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939922B (zh) * | 2005-09-27 | 2010-10-13 | 天津和美生物技术有限公司 | 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3，4-c]吡咯-4，6-二酮衍生物 |
| CN101186611B (zh) * | 2006-11-15 | 2011-05-18 | 天津和美生物技术有限公司 | 可抑制细胞释放肿瘤坏死因子的吡咯啉-2-酮衍生物及其制备和应用 |
| KR20170042598A (ko) | 2014-08-22 | 2017-04-19 | 셀진 코포레이션 | 항체와 조합된 면역조절 화합물을 이용하여 다발성 골수종을 치료하는 방법 |
| AU2016266942B2 (en) * | 2015-05-22 | 2018-10-18 | Biotheryx, Inc. | Compounds targeting proteins, compositions, methods, and uses thereof |
| CA3043938A1 (en) * | 2016-12-21 | 2018-06-28 | Biotheryx, Inc. | Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof |
-
2019
- 2019-06-11 CN CN201980039027.2A patent/CN112601751B/zh active Active
- 2019-06-11 CA CA3101335A patent/CA3101335C/en active Active
- 2019-06-11 AU AU2019284605A patent/AU2019284605A1/en not_active Abandoned
- 2019-06-11 US US16/438,244 patent/US11191769B2/en active Active
- 2019-06-11 WO PCT/US2019/036581 patent/WO2019241271A1/en not_active Ceased
- 2019-06-11 EP EP19739747.4A patent/EP3807283A1/en not_active Withdrawn
- 2019-06-11 JP JP2020569169A patent/JP7365059B2/ja active Active
- 2019-06-13 TW TW108120511A patent/TWI826463B/zh not_active IP Right Cessation
-
2021
- 2021-12-06 US US17/457,733 patent/US20220088025A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527098A5 (https=) | ||
| AU2019414550B2 (en) | FAK inhibitor and drug combination thereof | |
| RU2018104092A (ru) | Бициклические лактамы и способы их применения | |
| CN110573501A (zh) | Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途 | |
| JP2015535851A5 (https=) | ||
| RU2012151012A (ru) | Циклопропиловые дикарбоксамиды и аналоги, обладающие противораковым и антипролиферативным действием | |
| AR122010A1 (es) | Compuestos heterocíclicos como receptores desencadenantes expresados en agonistas de células mieloides 2 y métodos de uso | |
| JP2021532162A5 (https=) | ||
| JP2021533135A5 (https=) | ||
| AR109958A1 (es) | Lactamas bicíclicas de piridona y sus métodos de uso | |
| JPWO2019241271A5 (https=) | ||
| JP2016513660A5 (https=) | ||
| FI3810602T3 (fi) | Yhdisteitä | |
| CA3051645A1 (en) | Aryl hydrocarbon receptor (ahr) modulator compounds | |
| JP2021516237A5 (https=) | ||
| CA2579915A1 (en) | Indole derivatives and their use as inhibitors of p53-mdm2 interaction | |
| JP2008528467A5 (https=) | ||
| TR201809990T4 (en) | NEW COMPOSITIONS, USES AND METHODS FOR THEIR MAKING. | |
| JP2009543771A5 (https=) | ||
| RU2015153319A (ru) | Гетероциклическое соединение бензимидазол-2-пиперазин, его фармацевтическая композиция, а также препаративные методы и назначение | |
| RU2017139771A (ru) | Бициклические соединения | |
| JP2014520108A5 (https=) | ||
| RU2017109355A (ru) | Гетероциклические соединения и их применение | |
| US20130177529A1 (en) | Pyrazole Compounds | |
| JP2021523241A5 (https=) |